• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

3.900 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AtaiBeckley Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation
January 16, 2026
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
January 08, 2026
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Completes Redomiciliation to the United States
December 30, 2025
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
December 23, 2025
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
December 11, 2025
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
November 13, 2025
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 12, 2025
AtaiBeckley solidifies position as a global leader in transformative mental health therapies with a short psychedelic duration 
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
November 10, 2025
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
November 05, 2025
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
October 20, 2025
Cash, cash equivalents, short-term investments and other liquid assets expected to fund operations into 2029, beyond anticipated top-line results from the first Phase 3 clinical trial of BPL-003 
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Announces Pricing of Public Offering of Common Shares
October 16, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Announces Proposed Public Offering of Common Shares
October 16, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
October 16, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
September 23, 2025
From atai Life Sciences
Via GlobeNewswire
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
September 19, 2025
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
atai Life Sciences Awarded Grant from the National Institutes of Health
September 18, 2025
5-year UG3/UH3 grant will fund the optimization and early-stage development of atai’s novel 5-HT2A/2C receptor agonists with non-hallucinogenic potential for opioid use disorder 
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences to Participate in September Investor Conferences
August 28, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
August 14, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
July 25, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
From FN Media Group LLC
Via GlobeNewswire
News headline image
atai Life Sciences Announces $50 Million Private Placement Financing
July 01, 2025
Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1 
From atai Life Sciences
Via GlobeNewswire
News headline image
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders
June 15, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression
July 01, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders
June 03, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
June 02, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences to Participate in Upcoming Investor Conferences
May 29, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression
May 20, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates
May 14, 2025
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder
May 13, 2025
From atai Life Sciences
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap